Glaukos (GKOS) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)
Glaukos (GKOS) Net Income towards Common Stockholders Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 12.92% |
| 10 | Glaukos | 11.02 Bn | 10.90 Bn | 151.59 Mn | 6.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.29% |
| Mar 31, 2026 | -9.11% |
| Dec 31, 2025 | -2,219.67% |
| Sep 30, 2025 | 24.27% |
| Jun 30, 2025 | 61.11% |
| Mar 31, 2025 | 55.59% |
| Dec 31, 2024 | 63.62% |
| Sep 30, 2024 | 29.60% |
| Jun 30, 2024 | -54.04% |
| Mar 31, 2024 | -18.01% |
| Dec 31, 2023 | 64.44% |
| Sep 30, 2023 | -10.40% |
| Jun 30, 2023 | 27.94% |
| Mar 31, 2023 | -743.97% |
| Dec 31, 2022 | -43.26% |
| Sep 30, 2022 | -542.63% |
| Jun 30, 2022 | -160.47% |
| Mar 31, 2022 | 132.65% |
| Dec 31, 2021 | -92.88% |
| Sep 30, 2021 | 139.56% |